Is there still a place for unfractionated heparin in venous thromboembolism?
Meyer, G.
La Revue du Praticien 65(2): 199
2015
ISSN/ISBN: 0035-2640 PMID: 25939221 Document Number: 683002
Document emailed within 1 workday
Related Documents
Iorio, A.; Agnelli, G. 2000: Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: a meta-analysis Archives of Internal Medicine 160(15): 2327-2332Paglia, I.; Carrieri, L.; Oliaro, E.; Bergerone, S.; Mangiardi, L.; Trevi, G.P. 2002: A case of pulmonary thromboembolism after interruption of treatment with unfractionated heparin Minerva Cardioangiologica 50(4): 379-382
Osterkorn, D.; Schramm, W.; Szucs, T. 1996: Health care economics evaluation of inpatient treatment of venous thrombosis with unfractionated heparin versus subcutaneous low molecular weight heparin at home Medizinische Klinik 91(9): 607-609
Bernardi, E.; Piccioli, A.; Oliboni, G.; Zuin, R.; Girolami, A.; Prandoni, P. 2000: Nomograms for the administration of unfractionated heparin in the initial treatment of acute thromboembolism--an overview Thrombosis and Haemostasis 84(1): 22-26
Muraoka, M.; Mochinaga, K.; Sengyoku, H.; Ryu, C.; Ikuta, Y.; Tabuchi, S.; Satou, A.; Inamasu, E.; Tobinaga, S.; Komatsu, H.; Yamaguchi, H.; Kimino, K. 2013: Efficacy and safety of administration of low-dose unfractionated heparin (LDUH) for the prevention of pulmonary thromboembolism after surgery for lung cancer; the long term outcome Kyobu Geka. Japanese Journal of Thoracic Surgery 66(2): 93-100
Petrov, V.I.; Shatalova, O.V.; Maslakov, A.S.; Shatalov, A.A. 2014: The place of novel oral anticoagulants in prevention and treatment of venous thromboembolism Angiologiia i Sosudistaia Khirurgiia 20(3): 89-93
Jacobsen, A.F.; Qvigstad, E.; Sandset, P.M. 2000: Treatment of venous thromboembolism in pregnancy with low molecular weight heparin Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(20): 2448-2449
Bergqvist, D. 1990: Low molecular weight heparin--preventive supplementation against postoperative venous thromboembolism Lakartidningen 87(8): 562-564
Eriksson, E.; Wollter, I.M.; Christenson, B.; Stigendal, L.; Risberg, B. 1988: Heparin and fibrinolysis--comparison of subcutaneous administration of unfractionated and low molecular weight heparin Thrombosis and Haemostasis 59(2): 284-288
Godoy, I.; Herrera, C.; Zapata, C.; Kunstmann, S.; Abufhele, A.; Corbalán, R. 1998: Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina Revista Medica de Chile 126(3): 259-264
Merton, R.E.; Thomas, D.P.; Havercroft, S.J.; Barrowcliffe, T.W.; Lindahl, U. 1984: High and low affinity heparin compared with unfractionated heparin as antithrombotic drugs Thrombosis and Haemostasis 51(2): 254-256
Jacobs, C.; Grebe, S.; Kietzmann, M.; Mischke, R. 1999: Pharmacokinetics of an unfractionated heparin (Liquemin) in the dog after intravenous and subcutaneous application based on heparin activity Deutsche Tierärztliche Wochenschrift 106(11): 478-481
Chigot, P.; De Gennes, C.; Samama, M.M. 1996: Osteoporosis induced either by unfractionated heparin or by low molecular weight heparin Journal des Maladies Vasculaires 21(3): 121-125
Rogers, P.H.; Walsh, P.N.; Marder, V.J.; Bosak, G.C.; Lachman, J.W.; Ritchie, W.G.; Oppenheimer, L.; Sherry, S. 1978: Controlled trial of low-dose heparin and sulfinpyrazone to prevent venous thromboembolism after operation on the hip Journal of Bone and Joint Surgery. American Volume 60(6): 758-762
Kakkar, V.V.; Bentley, P.G.; Lawrence, D.; de Haas, H.A.; Ward, V.P. 1979: Prevention of postoperative venous thromboembolism by means of heparin and dihydroergotamine after hip joint replacement Münchener Medizinische Wochenschrift 121(36): 1152-1154
Couturaud, F.; Julian, J.A.; Kearon, C. 2001: Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis Thrombosis and Haemostasis 86(4): 980-984
Akaraborworn, O.; Chittawatanarat, K.; Chatmongkolchart, S.; Kitsiripant, C. 2016: Modalities in Venous Thromboembolism Prophylaxis and Symptomatic Venous Thromboembolism Occurrence in Critically Ill Surgical Patients (THAI-SICU Study) Journal of the Medical Association of Thailand 99(Suppl 6): S112-S117
von Felten, A. 1992: Prevention of venous thromboembolism with heparin in risk patients during pregnancy: monitoring by measuring thrombin-antithrombin III complex Therapeutische Umschau. Revue Therapeutique 49(12): 837-842
Gallus, A.S.; Goodall, K.T.; Tillett, J.; Jackaman, J.; Wycherley, A. 1987: The relative contributions of antithrombin III during heparin treatment, and of clinically recognisable risk factors, to early recurrence of venous thromboembolism Thrombosis Research 46(4): 539-553
Høibraaten, E.; Qvigstad, E.; Arnesen, H.; Larsen, S.; Wickstrøm, E.; Sandset, P.M. 2000: Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET) Thrombosis and Haemostasis 84(6): 961-967